7 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... infection Episode #Pharmacology ... #Management #CDiff ... #Clostridium #CDifficile ... IDSA2017 #Adjunct #Antibiotics
Anti-C. Difficile - Antibiotics Class Overview
 1. Metronidazole – (see anti-anaerobe section above for more details).
Difficile - Antibiotics ... therapy for severe C.diff ... Fidaxomicin (PO) #Pharmacology ... #Antibiotics #Review ... #Overview #CDifficile
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
with Community-Acquired ... fluoroquinolone #IDSA ... CAP #Community #Acquired ... #Pneumonia #Antibiotics ... Management #Guidelines #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Difficile Infection ... Perforation) Pathophysiology ... can be community-acquired ... Tx Management (IDSA ... ciab549 #CDI #Cdiff
Causes of Antibiotic Failure - Differential Diagnosis Framework
Diagnosis:
 • Non-Infectious: Malignant, Autoimmune, Drug-related (NMS, serotonin syndrome,
Causes of Antibiotic ... Treatment: • Antibiotic ... Secondary infection (C diff ... ) • Hospital-Acquired ... Difficile, COVID
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... tolerate appropriate antibiotic ... high risk for C. difficile ... not otherwise required ... nonoperative #management #IDSA
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Primary Clostridium difficile ... × 10 days #CDiff ... treatment #management #pharmacology ... #idsa #table